Literature DB >> 6609983

Biochemical comparison of murine colony-stimulating factors secreted by a T cell lymphoma and a myelomonocytic leukemia.

R L Prestidge, J D Watson, D L Urdal, D Mochizuki, P Conlon, S Gillis.   

Abstract

Factors that stimulate the proliferation and differentiation of murine bone marrow cells have been purified from a cloned T cell lymphoma, LBRM-33, and a cloned myelomonocytic leukemia cell line, WEHI-3. These colony-stimulating factors (CSF) have been purified by sequential fractionation by using salt precipitation, gel filtration, anion and cation exchange chromatography, and high pressure liquid chromatography. Both LBRM-33 and WEHI-3 cells secrete a CSF species with similar chemical and biologic properties. This CSF species appears to exist in two forms, termed CSF-2 alpha and CSF-2 beta, both of which stimulate the growth of bone marrow cells in the granulocyte, macrophage, megakaryocyte, mast cell, and erythrocyte lineages, as well as the growth of a CSF-dependent cell line, FDC-P2. These properties of CSF-2 alpha and -2 beta are similar to those reported for interleukin 3, hematopoietic cell growth factor, mast cell growth factor, and persisting cell growth factor. However, LBRM-33 cells secrete another CSF species, not produced by WEHI-3 cells. This CSF species, unique to LBRM cells, is termed here CSF-2 gamma and it stimulates the proliferation of granulocytes and macrophages from bone marrow but does not support the growth of FDC-P2 cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609983

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Differential induction of bone marrow macrophage proliferation by mycoplasmas involves granulocyte-macrophage colony-stimulating factor.

Authors:  P M Stuart; G H Cassell; J G Woodward
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  The magnitude of macrophage inflammatory response does not directly depend on ability of bone marrow cells to respond to interleukin-3 in mice of different strains.

Authors:  G N Pozzulo; E Skamene; F Gervais
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

3.  Comparative effects in vivo of recombinant murine interleukin 3, natural murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage colony-stimulating factor on myelopoiesis in mice.

Authors:  H E Broxmeyer; D E Williams; S Cooper; R K Shadduck; S Gillis; A Waheed; D L Urdal; D C Bicknell
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

4.  Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro.

Authors:  J A Lorenzo; S L Sousa; J M Fonseca; J M Hock; E S Medlock
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

5.  Augmentation of IgE receptor expression and IgE receptor-mediated phagocytosis of rat bone marrow-derived macrophages by murine interferons.

Authors:  G Boltz-Nitulescu; C Wiltschke; K Langer; H Nemet; C Holzinger; A Gessl; O Förster; E Penner
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

6.  Enhancement of fibroblast-dependent mast cell growth in mice by a conditioned medium of keratinocyte-derived squamous cell carcinoma cells.

Authors:  K Nakamura; T Tanaka; E Morita; Y Kameyoshi; S Yamamoto
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Role of macrophages in serum colony-stimulating factor induction by Lactobacillus casei in mice.

Authors:  M Nanno; T Shimizu; A Mike; M Ohwaki; M Mutai
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

8.  B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors.

Authors:  A E Namen; A E Schmierer; C J March; R W Overell; L S Park; D L Urdal; D Y Mochizuki
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

9.  Stimulation of mast cell chemotaxis by interleukin 3.

Authors:  N Matsuura; B R Zetter
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.